UK Artificial Intelligence (AI) in Healthcare Market (2025-2030)
The UK Artificial Intelligence (AI) in Healthcare Market was valued at $1072 Million in 2025 and projected to reach to $5839.6 Million by 2030, representing a compound annual growth rate of CAGR: 40.4%. The UK artificial intelligence in healthcare market is positioned for exceptional growth over the next five years, driven by increasing adoption of AI-powered diagnostic tools, clinical decision support systems, and administrative automation across NHS trusts and private healthcare providers.
UK Artificial Intelligence (AI) in Healthcare Market Trends and Insights
- The UK's advanced healthcare infrastructure, strong regulatory framework, and significant investment in digital health technologies are driving adoption of AI-powered diagnostic tools, clinical decision support systems, and administrative automation across the National Health Service and private providers.
- The UK's commitment to digital transformation in healthcare, combined with growing data availability and skilled AI talent, positions the country as a key growth hub for AI healthcare solutions in Europe. During the 2025–2030 forecast period, the UK market is expected to grow at a compound annual growth rate (CAGR) of 38.6%, reflecting accelerating integration of machine learning and natural language processing into clinical workflows.
- The UK's regulatory bodies, including the MHRA and NICE, are establishing clear pathways for AI medical device approval, reducing barriers to market entry and encouraging innovation.
- Investment from both public sector initiatives and private venture capital is fueling development of UK-based AI healthcare startups and expansion of multinational AI vendors in the region..
Key Market Statistics
- CAGR (2025-2030) CAGR: 40.4%
- Market Size, 2025 ~USD 1072 Million
- Forecast, 2030 ~USD 5839.6 Million
- Country UK
UK Artificial Intelligence (AI) in Healthcare Market Overview
Rapid Market Growth :
The UK AI in healthcare market is projected to grow from $21.63 million in 2025 to $110.61 million by 2030, representing a robust 40.4% CAGR, significantly outpacing the global average of 38.6%.
Advanced Healthcare Infrastructure :
The UK's mature NHS ecosystem, coupled with world-class medical institutions and digital health initiatives, creates an ideal environment for AI adoption in diagnostic imaging, clinical decision support, and administrative automation.
Strong Regulatory Framework :
The UK's established regulatory pathways through MHRA and NICE guidelines provide clear approval mechanisms for AI-powered medical devices and software, accelerating market entry and clinical implementation.
Strategic Digital Health Investment :
Significant government funding for digital transformation, including the NHS Long Term Plan and AI in Health and Care Award, is driving substantial investment in AI technologies across UK healthcare providers.
UK Artificial Intelligence (AI) in Healthcare Market Dynamics
- The convergence of advanced healthcare infrastructure, supportive regulatory frameworks, and substantial digital health investments creates a compelling market opportunity.
- Key growth drivers include rising demand for precision medicine, workforce optimization, and improved patient outcomes through AI-enabled analytics and predictive capabilities..
Related Ecosystem
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Healthcare Analytics
- Machine Learning
- Natural Language Processing (NLP)
- Blood Pressure Monitors
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Oracle Corporation
- PHILIPS HEALTHCARE
- Siemens healthineers
- Zensar Technologies Limited
- EPIC SYSTEMS CORPORATION
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- The UK AI in healthcare market is valued at $21.63 million in 2025 and is forecast to grow to $110.61 million by 2030, representing a 38.6% CAGR.
- The UK's robust regulatory environment and NHS digital transformation initiatives are accelerating AI adoption across diagnostic imaging, clinical decision support, and administrative applications.
- Strong government backing, including AI research funding and clear approval pathways from MHRA and NICE, positions the UK as a leading European hub for AI healthcare innovation.
- The UK market benefits from a combination of advanced healthcare infrastructure, abundant clinical data, and a skilled workforce, creating competitive advantages for both domestic startups and international vendors.
Artificial Intelligence (AI) in Healthcare Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Forecast Period | 2025–2039 |
| Growth Rate | CAGR of 38.6% from 2025 to 2039 |
| Market Size Base Year (Billions) | ~USD 21.63 (2025) |
| Revenue Forecast (Billions) | ~USD 110.61 (2039) |
| Segments Covered | Offering, Function, Type, Technology, Application, Modality, Deployment Model, Tool, End User |
UK Artificial Intelligence (AI) in Healthcare Market Report Segmentation
9 segment dimensions are covered across the global market.
By Offering
- AI Technologies
- Integrated Solutions
- Niche/Point Solutions
- Services
By Function
- Administrative
- Data Management & Analytics
- Diagnosis & Early Detection
- Patient Engagement & Remote Monitoring
- Pharmacy Management
- Post-Treatment Surveillance & Survivorship Care
- Treatment Planning & Personalization
By Type
- Ambulatory Care Centers
- Asset Management
- Auto Coding
- Behavioral Therapy & Psychotherapy
- Billing & Claims Management
- Classification & Categorization
- Compliance & Documentation
- Convolutional Neural Networks (Cnn)
- Customer Relationship Management
- Cybersecurity
- Deep Learning
- Device Context
- Diagnostic & Imaging Centers
- Diagnostic Imaging
- Diagnostics Imaging
- Dosing & Administration
- Drug Allergy Alerting
- Drug Response Prediction
- Eprescribing
- Follow-Up & Long-Term Support
- Fraud Detection & Risk Management
- Generative Adversarial Networks (Gan)
- Graph Neural Networks (Gnn)
- Healthcare Assistance Robots
- Healthcare Workflow Management
- Home Healthcare Agencies & Assisted Living Facilities
- Hospitals & Clinics
- Immunotherapy
- Intraoperative Guidance & Robotics
- Ivd
- Long-Term Outcome Prediction
- Medication Management
- Medication Reminders
- Mental Health & Support Systems
- Motion Synchronization & Auto Contouring
- Other Administrative Functions
- Other Deep Learning Tools
- Other Diagnosis & Early Detection Functions
- Other Healthcare Providers
- Other Machine Learning Tools
- Other ML Tools
- Other Patient Engagement & Remote Monitoring Functions
- Other Pharmacological Therapy Functions
- Other Pharmacy Management Functions
- Other Radiation Therapy Functions
- Other Treatment Planning & Personalization Functions
- Patient Education & Empowerment
- Patient Eligibility & Authorization
- Patient Registration & Scheduling
- Pattern & Image Recognition
- Personalized Treatment Planning
- Pharmacies
- Pharmacological Therapy
- Pharmacy Audit & Analysis
- Physical Context
- Postoperative Analysis & Recovery
- Pre-Screening
- Precision Medicine & Genomic Analysis
- Predictive Models For Treatment Response
- Preoperative Imaging & 3D Modeling
- Private Payers
- Progress Monitoring & Feedback
- Public Payers
- Radiation Therapy
- Real-Time Adaptive Treatment Delivery
- Real-Time Patient Data Monitoring
- Recurrence Monitoring
- Recurrent Neural Networks (Rnn)
- Reinforcement Learning
- Relapse Prediction & Long-Term Management
- Response & Side-Effect Prediction
- Response Assessment & Quality Assurance
- Risk Assessment & Patient Stratification
- Sentiment Analysis
- Speech Recognition
- Supervised Learning
- Supply Chain & Inventory Management
- Surgical Therapy
- Symptom Management & Virtual Assistance
- Telehealth & Remote Patient Monitoring
- Text Analytics
- Treatment Recommendation Systems
- Unsupervised Learning
- User Context
- Virtual Counseling & Chatbots
- Workforce Management
By Technology
- Clinical Chemistry
- Immunoassays
- Molecular Diagnostics
By Application
- Biomarker Discovery & Analysis
- Clinical Applications
- Disease Interpretation & Report Analysis
- Image Analysis & Interpretation
- Image Captioning & Annotation
- Image Reconstruction
- Non-Clinical Applications
- Other Diagnostic Imaging Applications
- Other Ivd Applications
By Modality
- Computed Tomography (Ct)
- Magnetic Resonance Imaging (Mri)
- Nuclear Imaging (Pet & Spect)
- Other Diagnostic Imaging Modalities
- Ultrasound
- X-Ray Imaging
By Deployment Model
- Cloud-Based Models
- Hybrid Models
- On-Premise Models
By Tool
- Computer Vision
- Context-Aware Computing
- Generative AI
- Image Analysis
- Machine Learning (ML)
- Natural Language Processing (Nlp)
By End User
- Healthcare Payers
- Healthcare Providers
- Other End Users
- Patients
Target Audience
- Healthcare Technology Vendors : AI software and device manufacturers need UK-specific market data to develop localized go-to-market strategies, understand NHS procurement processes, and identify clinical adoption barriers and opportunities.
- NHS Trusts & Healthcare Providers : Hospital networks and clinical organizations require market intelligence to evaluate AI solution investments, benchmark against peers, and align digital transformation initiatives with proven market trends and best practices.
- Private Equity & Venture Investors : Investment firms targeting UK healthcare AI need comprehensive market sizing, growth projections, and competitive analysis to identify high-potential portfolio companies and validate investment theses.
- Healthcare Consultants & Advisors : Management consulting firms and healthcare strategists require UK-specific market data to advise clients on digital transformation roadmaps, technology selection, and competitive positioning in the AI healthcare ecosystem.
- Government & Policy Makers : NHS leadership and health policy officials need evidence-based market insights to inform digital health strategy, funding allocation, and regulatory frameworks supporting AI adoption across the UK healthcare system.
Key Companies in the UK Artificial Intelligence (AI) in Healthcare Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| EPAM SYSTEMS, INC. | United States | ||
| SIEMENS AG | Germany | ||
| WNS GLOBAL SERVICES | India | ||
| L&T TECHNOLOGY SERVICES LIMITED | India | ||
| LARSEN & TOUBRO INFOTECH LIMITED | India | ||
| SOPRA STERIA | United States | ||
| CYIENT | India |
EPAM SYSTEMS, INC.
EPAM Systems, Inc. is a leading digital transformation and software engineering services company headquartered in the United States. The company provides consulting, software development, and IT services to clients across various industries globally.
SIEMENS AG
Siemens AG is a German multinational conglomerate providing automation, digitalization, and electrification solutions across industrial, infrastructure, and mobility sectors worldwide.
WNS GLOBAL SERVICES
WNS Global Services is an India-based business process management and IT services company offering customer engagement, finance and accounting, and technology solutions to global enterprises.
L&T TECHNOLOGY SERVICES LIMITED
L&T Technology Services Limited is an India-based engineering and technology services company providing design, engineering, and digital transformation solutions across multiple industries.
LARSEN & TOUBRO INFOTECH LIMITED
Larsen & Toubro Infotech Limited is an India-based IT services and consulting company offering digital transformation, cloud, and enterprise solutions to global clients.
SOPRA STERIA
Sopra Steria is a digital services and software company providing consulting, systems integration, and software development services, with operations in the United States and globally.
CYIENT
Cyient is an India-based engineering and technology services company specializing in digital, engineering, and cloud solutions for aerospace, defense, and industrial sectors.
Reasons to Buy this Report
- Market Size & Growth Validation : Comprehensive data validating the UK market's 40.4% CAGR trajectory, enabling confident investment decisions and strategic planning for market entry or expansion within the high-growth healthcare AI sector.
- Competitive Landscape Intelligence : Detailed insights into UK-specific market dynamics, key players, and competitive positioning to identify partnership opportunities, acquisition targets, and differentiation strategies in the rapidly evolving AI healthcare space.
- Regulatory & Compliance Roadmap : UK-focused analysis of MHRA approval pathways, NICE guidelines, and regulatory requirements essential for successfully launching AI solutions in the NHS and private healthcare sectors.
- Investment & Funding Opportunities : Identification of government grants, NHS procurement opportunities, and venture capital trends specific to UK AI healthcare, enabling strategic funding acquisition and partnership development.
- Segment & Application Insights : Granular breakdown of UK market segments including diagnostic imaging, clinical decision support, and administrative automation, revealing high-potential niches and implementation priorities for healthcare organizations.
Frequently asked questions
What is the current size of the UK AI in healthcare market?
The UK AI in healthcare market is valued at $21.63 million in 2025 and is expected to grow significantly over the forecast period.
What is the projected market size for UK AI in healthcare by 2030?
The UK AI in healthcare market is forecast to reach $110.61 million by 2030, growing at a CAGR of 38.6% from 2025 to 2030.
What are the main drivers of AI adoption in the UK healthcare sector?
Key drivers include NHS digital transformation initiatives, regulatory support from MHRA and NICE, government AI research funding, abundant clinical data, and a skilled workforce in the UK.
How does the UK regulatory environment support AI healthcare innovation?
The UK's MHRA and NICE have established clear approval pathways for AI medical devices, reducing barriers to market entry and encouraging innovation in the UK healthcare AI sector.
What applications of AI are most prevalent in the UK healthcare market?
The UK healthcare market is seeing significant adoption of AI in diagnostic imaging, clinical decision support systems, administrative automation, and predictive analytics across NHS and private providers.
RESEARCH METHODOLOGY
The study involved significant efforts to estimate the current size of the artificial intelligence (AI) in healthcare market. Exhaustive secondary research was conducted to collect information on the artificial intelligence (AI) in healthcare market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the artificial intelligence (AI) in healthcare market.
Secondary Research
This research study involved the extensive use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers, annual reports, and Companies House documents; investor presentations; and companies' SEC filings. The market for companies offering artificial intelligence (AI) in healthcare solutions is derived from secondary data available through paid and unpaid sources, analysis of the product portfolios of major companies in the ecosystem, and ratings of companies based on performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, company investor presentations, white papers, journals, certified publications, articles by recognized authors, directories, and databases.
Various secondary sources were consulted during the secondary research process to identify and collect information relevant to the study. These sources included annual reports, press releases, investor presentations of artificial intelligence (AI) in healthcare vendors, forums, certified publications, and whitepapers. Secondary research was used to obtain critical information on the industry’s value chain, the pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess prospects.
Primary research was conducted to identify segmentation types, key players, and key market dynamics, including drivers, restraints, opportunities, challenges, and strategies adopted by key players.
After the complete market engineering (calculations for market statistics, market breakdown, market size estimates, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived.
In the complete market engineering process, top-down and bottom-up approaches, along with several data triangulation methods, were extensively used to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted on the complete market engineering process to identify key information/insights throughout the report.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by offering, function, application, deployment, tool, end user, and region).
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the artificial intelligence (AI) in healthcare market.
Market Definition
The artificial intelligence (AI) in healthcare market encompasses the application of AI technologies, such as machine learning, natural language processing, computer vision, and robotics, to improve healthcare delivery, enhance operational efficiency, and provide personalized care. These solutions address a wide range of use cases, including diagnostic imaging, predictive analytics, drug discovery, patient engagement, remote monitoring, and administrative workflows, enabling healthcare providers, payers, and pharmaceutical companies to drive innovation and improve outcomes.
Key Stakeholders
- Artificial intelligence (AI) in healthcare software vendors
- Artificial intelligence (AI) in healthcare service providers
- Independent software vendors (ISVs)
- Platform providers
- Technology providers
- System integrators
- Cloud service providers
- Healthcare IT service providers
- Hospitals and surgical centers
- Diagnostic imaging centers
- Academic institutes and research laboratories
- Forums, alliances, and associations
- Government organizations
- Institutional investors and investment banks
- Investors/Shareholders
- Venture capitalists
- Research and consulting firms
Report Objectives
- To define, describe, and forecast the global artificial intelligence (AI) in healthcare market based on offering, function, application, deployment, tool, end user, and region
- To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall artificial intelligence (AI) in healthcare market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the artificial intelligence (AI) in healthcare market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
- To track and analyze competitive developments such as product & service launches; expansions; partnerships, agreements, and collaborations; and acquisitions in the artificial intelligence (AI) in healthcare market
- To benchmark players within the artificial intelligence (AI) in healthcare market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Europe artificial intelligence (AI) in healthcare market into Denmark, Norway, and others
- Further breakdown of the Rest of Asia Pacific artificial intelligence (AI) in healthcare market into Vietnam, New Zealand, Australia, South Korea, and others
Get the Full Artificial Intelligence (AI) in Healthcare Market Report
Full forecast, segment splits, and company analysis for all Artificial Intelligence (AI) in Healthcare Market.
- US Artificial Intelligence (AI) in Healthcare Market
- Canada Artificial Intelligence (AI) in Healthcare Market
- Germany Artificial Intelligence (AI) in Healthcare Market
- France Artificial Intelligence (AI) in Healthcare Market
- Italy Artificial Intelligence (AI) in Healthcare Market
- Spain Artificial Intelligence (AI) in Healthcare Market
- China Artificial Intelligence (AI) in Healthcare Market
- Japan Artificial Intelligence (AI) in Healthcare Market
- India Artificial Intelligence (AI) in Healthcare Market
- Brazil Artificial Intelligence (AI) in Healthcare Market
- Mexico Artificial Intelligence (AI) in Healthcare Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report